These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18463329)

  • 1. Treatment-experienced breast cancer: new pathways for improving survival. Introduction.
    Waddell JA
    Am J Health Syst Pharm; 2008 May; 65(10 Suppl 3):S2-3. PubMed ID: 18463329
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer.
    Hamilton BK; Rybicki L; Abounader D; Andresen S; Kalaycio M; Sobecks R; Pohlman B; Hanna R; Dean R; Liu H; Hill B; Bolwell B; Copelan E
    Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):115-24. PubMed ID: 26183670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients.
    Santini D; Vincenzi B; Adamo V; Addeo R; Fusco V; Russo A; Montemurro F; Roato I; Redana S; Lanzetta G; Satolli MA; Berruti A; Leoni V; Galluzzo S; Antimi M; Ferraro G; Rossi M; Del Prete S; Valerio MR; Marra M; Caraglia M; Tonini G
    Oncol Rep; 2011 Jun; 25(6):1545-8. PubMed ID: 21455582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction: chemotherapies in the treatment of breast cancer.
    Fojo AT
    Semin Oncol; 2005 Dec; 32(6 Suppl 7):S1-2. PubMed ID: 16360715
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical outcomes of patients with breast cancer in a phase I clinic: the M. D. Anderson cancer center experience.
    Wheler J; Tsimberidou AM; Moulder S; Cristofanilli M; Hong D; Naing A; Pathak R; Liu S; Feng L; Kurzrock R
    Clin Breast Cancer; 2010 Feb; 10(1):46-51. PubMed ID: 20133258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese female breast cancer patients show a better overall survival than their male counterparts.
    Xia LP; Zhou FF; Guo GF; Wang F; Wang X; Yuan ZY; Zhang B
    Chin Med J (Engl); 2010 Sep; 123(17):2347-52. PubMed ID: 21034547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test may help predict chemotherapy response and survival in breast cancer.
    Printz C
    Cancer; 2011 Oct; 117(19):4339. PubMed ID: 21928334
    [No Abstract]   [Full Text] [Related]  

  • 8. [San Antonio Breast Cancer Symposium 2003. New therapeutic prospects in the treatment of early-stage breast cancer].
    Montemurro F
    Tumori; 2004; 90(1):suppl 1-16. PubMed ID: 15143995
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast cancer: five-year survival in Srinagarind Hospital, Thailand.
    Aphinives P; Punchai S; Vajirodom D; Bhudhisawasdi V
    J Med Assoc Thai; 2010 Mar; 93 Suppl 3():S25-9. PubMed ID: 21299088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of cyclooxygenase-2 and response to chemotherapy in invasive ductal breast carcinoma patients by real time surface plasmon resonance analysis.
    Singh AK; Parshad R; Pasi S; Madhavan T; Das SN; Mishra B; Gill K; Dalal K; Dey S
    DNA Cell Biol; 2011 Oct; 30(10):801-7. PubMed ID: 21476934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic resistance to chemotherapy in breast cancer.
    Moulder S
    Womens Health (Lond); 2010 Nov; 6(6):821-30. PubMed ID: 21118040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group.
    Franco Pérez F; Lavernia J; Aguiar-Bujanda D; Miramón J; Gumá J; Álvarez R; Gómez-Codina J; Arroyo FG; Llanos M; Marin M; Alfaro J; Quero C; Delgado M; Nogales E; Menarguez F; Martinez N; Torrente M; Royuela A; Abreu D; Provencio M
    Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):186-191. PubMed ID: 27847267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic options in locally advanced breast cancers].
    Angelescu N; Florea I; Jitea N; Burcoş T; Iosif A; Mihai C; Filipescu G; Bordea A
    Chirurgia (Bucur); 1995; 44(4):17-20. PubMed ID: 8646023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer.
    DeMichele A; Yee D; Esserman L
    N Engl J Med; 2017 Dec; 377(23):2287-2289. PubMed ID: 29211674
    [No Abstract]   [Full Text] [Related]  

  • 15. [Principles of adjuvant drug therapy in breast cancer].
    Castiglione M; Schnürch HG; Bender HG; Goldhirsch A
    Gynakologe; 1994 Apr; 27(2):49-63. PubMed ID: 8039743
    [No Abstract]   [Full Text] [Related]  

  • 16. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer.
    Derin D; Eralp Y; Ozluk Y; Yavuz E; Guney N; Saip P; Igci A; Ozmen V; Kücücük S; Aslay I; Aydiner A; Topuz E
    Cancer Invest; 2008 Aug; 26(7):671-9. PubMed ID: 18608215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotypes of XRCC1 and survival outcome in patients with metastatic breast cancer.
    Bewick MA; Conlon MS; Lafrenie RM
    Breast Cancer Res Treat; 2009 Oct; 117(3):667-9. PubMed ID: 19127428
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving the efficacy of trastuzumab in breast cancer.
    Suzuki E; Toi M
    Cancer Sci; 2007 Jun; 98(6):767-71. PubMed ID: 17428260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant systemic therapy of breast carcinoma].
    Wickramanayake PD; Katay I; Josting A; Diehl V
    Med Klin (Munich); 1996 Oct; 91(10):646-53. PubMed ID: 9019642
    [No Abstract]   [Full Text] [Related]  

  • 20. Can patients with metastatic breast cancer be cured after introduction of newer and more effective agents?
    Ohno S; Tanaka K; Koga C; Nishimura S; Yamaguchi H; Kawaguchi H; Yoshiyama T; Nakamura Y
    Breast Cancer; 2012 Jul; 19(3):212-7. PubMed ID: 21630056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.